MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE:MDT) today provided revenue and diluted earnings per share (EPS) guidance for fiscal year 2010. For fiscal year 2010, the company expects revenue growth in the range of 5-8 percent on a constant currency basis. The company also expects diluted earnings per share (EPS) in the range of $3.10 to $3.20, which reflects EPS growth in the range of 8-12 percent after adjusting for approximately 6-7 cents of earnings dilution from the recent acquisitions of CryoCath, Ablation Frontiers, Ventor, and CoreValve.
